Please login to the form below

Not currently logged in
Email:
Password:

Alzheimer's drug

This page shows the latest Alzheimer's drug news and features for those working in and with pharma, biotech and healthcare.

TauRx shares phase 3 trial data for Alzheimer's drug

TauRx shares phase 3 trial data for Alzheimer's drug

The trial assessed TauRx’s lead investigative oral drug, HMTM, which has been tested in 598 people diagnosed with Alzheimer’s. ... He added: “Today with limited treatments for Alzheimer’s, the standard of care does not impact the underlying

Latest news

More from news
Approximately 7 fully matching, plus 147 partially matching documents found.

Latest Intelligence

  • Alzheimer’s disease: the search for a cure Alzheimers disease: the search for a cure

    We are expecting to see the outcomes of an FDA priority review of the potential Alzheimer’s drug, aducanumab, this year. ... Over the past two decades, Alzheimer’s drug discovery has largely focused on targeting the hallmark amyloid protein.

  • Alzheimer’s: the search for a cure Alzheimers: the search for a cure

    Tau is emerging as a target for drug development in Alzheimer’s, as well as other disorders like frontotemporal dementia. ... Organisations including the Alzheimer’s Drug Discovery Foundation (ADDF) think combinations of molecules with these

  • Detecting Alzheimer’s ahead of a cure Detecting Alzheimers ahead of a cure

    Biogen and Eisai also pulled the plug on their Alzheimer’s drug aducanumab, after advice from an independent data monitoring committee forced them to abandon the phase 3 Abeta-targeting candidate. ... It was just another in a string of late-stage

  • Where next in Alzheimer’s disease R&D? Where next in Alzheimers disease R&D?

    This evidence has spurred research and led. organisations including the Alzheimer’s Drug Discovery Foundation and AC Immune to conclude that combination therapies may be needed to tackle such a complex ... Read more: Brain power: fresh approaches to

  • Brain power: fresh approaches to Alzheimer’s drug discovery Brain power: fresh approaches to Alzheimers drug discovery

    Two further candidates, AL003 for Alzheimer’s disease and AL004 for multiple degenerative disorders, are also set to enter clinical trials this year. ... Diseases include Alzheimer’s, dementia with Lewy bodies, frontotemporal dementia, as well as

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

  • Bone Therapeutics looks to Pfizer for clinical head Bone Therapeutics looks to Pfizer for clinical head

    He has spent a majority of his career at Pfizer, where he held a number of senior roles including medical director for Pfizer Switzerland, European team leader for the Alzheimer's ... disease drug Aricept and medical team leader for its anti-inflammatory

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....